ACU Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges PCRX Q1 2026 Earnings EPS Beat in a Quiet Quarter CRMT Q1 2026 Earnings Massive EPS Miss as Losses Widen Beyond Expectations Actuate Therapeutics Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss Jacobs Solutions J Q1 2026 Earnings EPS Surpasses Estimates by Nearly 5 BSRR Q1 2026 Earnings EPS Beat of 1438 Overshadowed by Slight Stock Decline